Y 25510

Known as: Y-25510 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-1998
01219921998

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Objective: Y-25510 was administered by means of an intravenous drip infusion to healthy adult male volunteers at a dose of 40, 80… (More)
  • table 1
  • figure 1
  • figure 2
  • table 3
  • table 4
Is this relevant?
1996
1996
The serum concentrations of interleukin(IL)-1 alpha and IL-6 in C57BL/6 and C3H/HeN mice reached the maximum at 12-16 h after the… (More)
Is this relevant?
1996
1996
(+/-)-3-[4-(2-Dimethylamino-1-methylethoxy)phenyl]-1H-pyrazolo[3, 4-b]pyridine-1-acetic acid (Y-25510) stimulated the mRNA… (More)
Is this relevant?
1992
1992
The effect of a novel synthetic compound, Y-25510, (+-)-3-[4-(2-dimethylamino-1-methylethoxy)phenyl]-1H-pyrazolo[3,4 -b] pyridine… (More)
Is this relevant?